Pfizer (PFE)
30.11
+0.67 (2.28%)
Upcoming Events
Latest Headlines
Form 4 PFIZER INC For: Oct 15 Filed by: BOURLA ALBERT
October 16, 2026 6:53 PM - SEC Filing
Pfizer (PFE) Reiterated at Neutral by Cantor Fitzgerald
October 16, 2026 7:33 AM - StreetInsider
Form 4 PFIZER INC For: Oct 13 Filed by: BOURLA ALBERT
October 14, 2026 4:49 PM - SEC Filing
Pfizer to present infectious disease data at IDWeek 2026
October 14, 2026 6:46 AM - StreetInsider
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
October 14, 2026 6:45 AM - BizWire
Guggenheim Reiterates Buy Rating on Pfizer (PFE)
October 13, 2026 7:17 AM - StreetInsider
Pfizer (PFE) PT Raised to $30 at JPMorgan
October 9, 2026 8:06 AM - StreetInsider
Pfizer (PFE) PT Raised to $28 at Cantor Fitzgerald on Growing Sector Tailwinds
October 8, 2026 7:17 AM - StreetInsider
FDA approves Pfizer's Tukysa as front-line maintenance for HER2+ breast cancer
October 7, 2026 12:57 PM - StreetInsider
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
October 7, 2026 12:57 PM - BizWire
Pfizer to cut 330 jobs at Sicily plant, unions say
October 7, 2026 10:28 AM - StreetInsider
Pfizer (PFE) PT Raised to $33 at Scotiabank
October 7, 2026 6:35 AM - StreetInsider
Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026
October 6, 2026 7:30 PM - PR NewsWire
Pfizer Declares Fourth-Quarter 2026 Dividend
October 6, 2026 10:00 AM - BizWire
Pfizer's Litfulo meets Phase 3 endpoints for vitiligo treatment
October 2, 2026 11:18 AM - StreetInsider
Pfizer’s LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo
October 2, 2026 11:15 AM - BizWire
Form 4 PFIZER INC For: Sep 30 Filed by: BOURLA ALBERT
October 1, 2026 2:05 PM - SEC Filing
Florida sues Pfizer over Covid-19 vaccine safety claims
October 1, 2026 1:14 PM - StreetInsider
Florida attorney general sues Pfizer over COVID-19 vaccine marketing claims
October 1, 2026 12:02 PM - StreetInsider
Pfizer's tilrekimig meets primary endpoint in phase 2 eczema trial
October 1, 2026 2:30 AM - StreetInsider
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
October 1, 2026 2:30 AM - BizWire
Trump praises Lilly, Merck, Pfizer investments
September 30, 2026 2:23 PM - StreetInsider
Form 4 PFIZER INC For: Sep 25 Filed by: Buckley Mortimer J
September 29, 2026 2:26 PM - SEC Filing
Form 4 PFIZER INC For: Sep 25 Filed by: Echevarria Joseph
September 29, 2026 2:26 PM - SEC Filing
Form 4 PFIZER INC For: Sep 25 Filed by: NARAYEN SHANTANU
September 29, 2026 2:26 PM - SEC Filing
Form 4 PFIZER INC For: Sep 25 Filed by: Quincey James
September 29, 2026 2:26 PM - SEC Filing
Form 4 PFIZER INC For: Sep 25 Filed by: SMITH JAMES C
September 29, 2026 2:25 PM - SEC Filing
Form 4 PFIZER INC For: Sep 25 Filed by: Taraporevala Cyrus
September 29, 2026 2:25 PM - SEC Filing
Pfizer to present 45 cancer abstracts at ESMO 2026 congress
September 28, 2026 6:45 AM - StreetInsider
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
September 28, 2026 6:45 AM - BizWire
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
September 22, 2026 10:00 AM - BizWire
Form 4 PFIZER INC For: Sep 15 Filed by: BOURLA ALBERT
September 16, 2026 3:18 PM - SEC Filing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 15, 2026 10:00 AM - BizWire
A $57 Billion Antiviral Market Is Taking Shape As The World Prepares For The Next Viral Threat
September 15, 2026 9:00 AM - StreetInsider
Pfizer (PFE) PT Raised to $30 at HSBC
September 10, 2026 3:29 AM - StreetInsider
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
September 8, 2026 10:00 AM - BizWire
Form 4 PFIZER INC For: Aug 31 Filed by: BOURLA ALBERT
September 1, 2026 5:54 PM - SEC Filing
Form N-PX PFIZER INC For: Jun 30
August 31, 2026 4:04 PM - SEC Filing
Form 3 PFIZER INC For: Aug 17 Filed by: Guegan Cecile
August 28, 2026 2:37 PM - SEC Filing
FDA approves Pfizer-BioNTech XFG-targeted Covid-19 vaccine
August 27, 2026 4:30 PM - StreetInsider
Form 4 PFIZER INC For: Aug 14 Filed by: BOURLA ALBERT
August 17, 2026 6:15 PM - SEC Filing
EMA validates Pfizer and Valneva's Lyme disease vaccine application
August 14, 2026 1:00 AM - StreetInsider
Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency
August 14, 2026 1:00 AM - StreetInsider
Form 13F-HR PFIZER INC For: Jun 30
August 13, 2026 4:44 PM - SEC Filing
Form 4 PFIZER INC For: Aug 12 Filed by: BOURLA ALBERT
August 12, 2026 4:05 PM - SEC Filing
PFE builds bull case at $26 after earnings beat and insider buys
August 7, 2026 9:42 AM - StreetInsider
Pfizer (PFE) PT Lowered to $29 at Bernstein SocGen Group
August 7, 2026 9:11 AM - StreetInsider
Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
August 6, 2026 4:36 PM - StreetInsider
Form 4 PFIZER INC For: Aug 05 Filed by: DAMICO JENNIFER B.
August 6, 2026 11:27 AM - SEC Filing
Form 4 PFIZER INC For: Aug 05 Filed by: BLAYLOCK RONALD E
August 5, 2026 4:05 PM - SEC Filing
Form 4 PFIZER INC For: Aug 05 Filed by: Buckley Mortimer J
August 5, 2026 4:03 PM - SEC Filing
Form 10-Q PFIZER INC For: Jun 28
August 4, 2026 7:05 AM - SEC Filing
Form 8-K PFIZER INC For: Aug 04
August 4, 2026 7:03 AM - SEC Filing
Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
August 4, 2026 6:47 AM - StreetInsider
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
August 4, 2026 6:45 AM - BizWire
Pfizer Q2 earnings preview: Analysts eye pipeline updates, portfolio resilience
August 3, 2026 11:30 PM - StreetInsider
Form 4 PFIZER INC For: Jul 31 Filed by: BOURLA ALBERT
August 3, 2026 7:51 PM - SEC Filing
Pfizer (PFE) call put ratio 1.1 calls to 1 put into quarter results
August 3, 2026 10:54 AM - StreetInsider
Pfizer (PFE) call put ratio 1.9 calls to 1 put into quarter results
August 3, 2026 6:02 AM - StreetInsider
U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
August 1, 2026 10:00 AM - StreetInsider
Pfizer's Litfulo meets Phase 3 goals in vitiligo skin condition
July 30, 2026 6:45 AM - StreetInsider
Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo
July 30, 2026 6:45 AM - BizWire
FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
July 22, 2026 4:30 PM - StreetInsider
FDA Grants Priority Review for Pfizer’s TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer
July 22, 2026 4:30 PM - BizWire
Full Article List
